Health
Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22
BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...
2021-01-14 19:00
10866
Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference
INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference.John Rim, newly appointed President and CEO, unveiled a multidimensional business plan for the company to furt...
2021-01-13 23:17
7763
China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL
SUZHOU and SHANGHAI, China, Jan. 13, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted approval fo...
2021-01-13 21:00
1921
ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut
LOS ANGELES, Jan. 13, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF, "ATIF"), a company providing business consulting and media services in Asia and North America, announces the client ofATIF, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding...
2021-01-13 21:00
10271
GenScript Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening
PISCATAWAY, N.J., Jan. 13, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading research reagent provider, announced today that it has submitted an application to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 N...
2021-01-13 20:30
5792
Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts
SHANGHAI, Jan. 13, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-sponsored the National Annual ...
2021-01-13 19:30
4043
VesCir poised to revolutionize skincare industry at CES 2021 with AI-driven 'iCi' skincare system
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Taiwanese biotech startup, VesCir, inspired by Nasa's Skin.B project, will have a launch of its ownthis year at CES 2021, where it will showcase its medical grade portable dynamic skincare system; a first on the market. The future of skincare now; "Dynamic...
2021-01-13 09:33
2073
CES 2021 PenguinSmart's intelligent and individualized rehab therapy helps children improve speech and language delays
TAIPEI, Jan. 12, 2021, /PRNewswire/ -- Globally, there are one in six children experiencing developmental delays. To minimize the impact developmental delays have on the child's life, it is best to detect and correct the delays before the child is 6 years old. PenguinSmart is a digital healthcare...
2021-01-13 04:55
4272
CES 2021 Taiwanese biotech startup mProbe CADx develops AI health analysis platform
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- mProbe Taiwan is a subsidiary biotechnology company of mProbe Inc, committed to promoting human health and wellness by transforming the field of precision health and precision medicine. With multi-omics as the critical evidence, mProbe has endeavored to inter...
2021-01-13 02:49
1852
CES 2021 PressureDOT develops the world's smallest real-time wireless intra-abdominal pressure sensing capsule
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Hospitals and health systems across the world are looking at telehealth strategies to facilitate their advance into the telemedicine industry. PressureDOT is at the forefront of remote critical monitoring with its recently developed, world's smallest wireless...
2021-01-12 22:46
1442
CES 2021 Taiwan startup Singular Wings Medical breaks the challenges of OSA diagnosis with AI
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Sleep apnea, also known as obstructive sleep apnea (OSA), is a hidden issue in modern society that still awaits an effective cure. Research suggests that 30% of the global population have sleeping disorders. People with the condition face a 6 times higher ...
2021-01-12 22:45
1569
CES 2021 Improve your health with Gene-Hub's Meta G - The world's first handheld device for metabolic analysis
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- The overweight population is continuing to rise rapidly worldwide. According to WHO, nearly 39% of adults worldwide are overweight. Furthermore, the global weight management market is expected to top US$ 294.2 billion in 2027. One of the ways to control body ...
2021-01-12 22:23
1442
CES 2021 Taiwanese startup developed dentall HiS: The next generation dental software system
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- dentall Global introduces the dentall HiS software, an E-commerce platform for dental supply, online/offline lecture and management consulting. The company intends to implement the software with multiple functions including ERP, CRM, billing and AI image sour...
2021-01-12 20:01
1811
IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection
OSAKA, Japan, Jan. 12, 2021 /PRNewswire/ -- H. IKEUCHI & CO., LTD., a leading manufacturer of industrial and commercial spray nozzles, headquartered inJapan, has launched full-scale sales of a backpack disinfection device dubbed "Dry-Fog HIGHNOW (R)." Logo: https://kyodonewsprwire.jp/prwfile/re...
2021-01-12 16:00
1405
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received
FDA clearance for its novel neuroendoscope, the Axonpen System, for
illumination and visualization of intracranial tissue and fluids, and the
controlled aspiration of tissue and/or fluid during surgery.
2021-01-12 01:00
1347
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...
2021-01-11 22:00
4803
ICON.AI launches World's First Smart Healthcare Device to protect your health at CES 2021
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- ICON.AI unveiled the World 1 st Smart Healthcare Device during CES 2021.   World 1st Smart Healthcare Device with Alexa Built-in With just One Touch of the Detachable Health Tracker, the Smart Healthcare Device takes comprehen...
2021-01-11 21:21
2076
PharmAbcine announces a research collaboration with LegoChem Biosciences
DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...
2021-01-11 21:00
1615
Happiness Biotech's E-Commerce Business - Happy Buy, Achieved Over 70% Growth in December
NANPING, China, Jan. 11, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, has achiev...
2021-01-11 21:00
7151
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients inGreater China, announced today the closing of a$150 million Series B financing. The round...
2021-01-09 11:06
5914
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
Asia Pacific Defies Global Headwinds: Mastercard Economics Institute 2026 Outlook
[Picked up by 277 media titles]
2025-12-10 09:00